- Home
- APVO
as 07-26-2024 4:00pm EST
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 1.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 18.1M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -92.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.28 - $48.40 | Next Earning Date: | 08-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Aptevo Therapeutics Inc. News
APVO Breaking Stock News: Dive into APVO Ticker-Specific Updates for Smart Investing
ACCESSWIRE
25 days ago
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
ACCESSWIRE
a month ago
Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules
ACCESSWIRE
2 months ago
Aptevo Participating in the BIO International Convention
ACCESSWIRE
2 months ago
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
ACCESSWIRE
3 months ago
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
ACCESSWIRE
3 months ago
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
ACCESSWIRE
4 months ago
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
ACCESSWIRE
4 months ago
Aptevo Therapeutics Provides Pipeline Update
Compare APVO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "APVO Aptevo Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.